CA2071638A1 - Methode de prevision des risques de l'atherosclerose - Google Patents

Methode de prevision des risques de l'atherosclerose

Info

Publication number
CA2071638A1
CA2071638A1 CA002071638A CA2071638A CA2071638A1 CA 2071638 A1 CA2071638 A1 CA 2071638A1 CA 002071638 A CA002071638 A CA 002071638A CA 2071638 A CA2071638 A CA 2071638A CA 2071638 A1 CA2071638 A1 CA 2071638A1
Authority
CA
Canada
Prior art keywords
resonance
hdl
plasma
standard
ldl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002071638A
Other languages
English (en)
Inventor
Eric T. Fossel
Jan Mcdonagh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2071638A1 publication Critical patent/CA2071638A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
CA002071638A 1989-12-21 1990-12-21 Methode de prevision des risques de l'atherosclerose Abandoned CA2071638A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45406989A 1989-12-21 1989-12-21
US454,069 1989-12-21
US63052090A 1990-12-20 1990-12-20
US630,520 1990-12-20

Publications (1)

Publication Number Publication Date
CA2071638A1 true CA2071638A1 (fr) 1991-06-22

Family

ID=27037331

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002071638A Abandoned CA2071638A1 (fr) 1989-12-21 1990-12-21 Methode de prevision des risques de l'atherosclerose

Country Status (7)

Country Link
EP (1) EP0509049A1 (fr)
JP (1) JPH06505089A (fr)
AU (1) AU7142991A (fr)
BR (1) BR9007936A (fr)
CA (1) CA2071638A1 (fr)
FI (1) FI922887A0 (fr)
WO (1) WO1991010128A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3021874B1 (fr) * 2013-07-18 2022-04-27 The University of Hong Kong Procédés de classification de liquide pleural

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021517A1 (fr) * 1992-04-10 1993-10-28 The Beth Israel Hospital Association MESURE DE PROPENSION A l'ATHEROSCLEROSE; CAPACITE D'OXYDATION DE RESIDUS D'OLEFINES DES LIPOPROTEINES ET DES LIPIDES DU PLASMA
NZ275054A (en) * 1993-11-08 1997-04-24 Peptide Delivery Systems Pty L Diagnosing atherosclerosis or coronary artery disease using labelled composition which mimics essential features of an exogenous lipoprotein
US6653140B2 (en) 1999-02-26 2003-11-25 Liposcience, Inc. Methods for providing personalized lipoprotein-based risk assessments
AU2054000A (en) 1999-02-26 2000-09-14 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
ATE319105T1 (de) 1999-04-22 2006-03-15 Liposcience Inc Nmr-verfahren zur bestimmung des risikos zur entwicklung von diabetes type 2
CA2331116A1 (fr) 2001-01-15 2002-07-15 Chenomx, Inc. Identification et quantification de composes aqueux--technique et procede utilisant un systeme automatise de mesure a resonance magnetique nucleaire
US20050130321A1 (en) 2001-04-23 2005-06-16 Nicholson Jeremy K. Methods for analysis of spectral data and their applications
WO2002086502A2 (fr) * 2001-04-23 2002-10-31 Metabometrix Limited Procedes de diagnostic et de traitement de maladies des os
NL1021753C2 (nl) * 2002-10-25 2004-04-27 Tno Detectie van osteoarthritis.
US9551768B2 (en) 2013-03-15 2017-01-24 East Carolina University NMR method for monitoring changes in the core of lipoprotein particles in metabolism and disease
US10775458B2 (en) 2018-03-05 2020-09-15 Texas Tech University System Method and system for non-invasive measurement of metabolic health
CN110082532A (zh) * 2019-05-20 2019-08-02 吉林瑞特生物科技有限公司 脂蛋白a测定试剂盒及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200588A (en) * 1973-11-16 1980-04-29 The Upjohn Company Polycycloanilines
IL81276A (en) * 1986-02-26 1991-05-12 Beth Israel Hospital Process for the screening of cancer using nuclear magnetic resonance spectroscopy
US4940055A (en) * 1987-11-03 1990-07-10 University Of Virginia Alumni Patents Foundation High-resolution spectral signature of human arterial plaque
US4933844A (en) * 1988-09-26 1990-06-12 Otvos James D Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3021874B1 (fr) * 2013-07-18 2022-04-27 The University of Hong Kong Procédés de classification de liquide pleural

Also Published As

Publication number Publication date
EP0509049A1 (fr) 1992-10-21
BR9007936A (pt) 1992-10-27
EP0509049A4 (fr) 1992-08-27
AU7142991A (en) 1991-07-24
WO1991010128A1 (fr) 1991-07-11
FI922887A (fi) 1992-06-18
FI922887A0 (fi) 1992-06-18
JPH06505089A (ja) 1994-06-09

Similar Documents

Publication Publication Date Title
EP0361214B1 (fr) Analyse de lipoprotéines du sang par RMN
CA2568705C (fr) Procede permettant de determiner la densite de lipoproteines dans des fluides corporels
Cheng et al. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens
Liu et al. Use of 1H NMR‐determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma
CA2071638A1 (fr) Methode de prevision des risques de l'atherosclerose
EP2744406B1 (fr) Procédé et système de résonance magnétique pour la quantification de la graisse hépatique chez l'homme
US5261405A (en) Apparatus and method for detecting cancer using nuclear magnetic resonance
US5207715A (en) Method of detecting cancer by measuring lipid-peroxidation using NMR
Schiller et al. Evaluation of cartilage composition and degradation by high-resolution magic-angle spinning nuclear magnetic resonance
US4918021A (en) Process for the detection of cancer
Bell et al. Factors affecting 1H NMR spectra of blood plasma: cancer, diet and freezing
EP0234524B1 (fr) Procédé pour la détection du cancer utilisant la résonance magnétique nucléaire
Benaki et al. NMR-based metabolic profiling procedures for biofluids and cell and tissue extracts
IE912581A1 (en) Method of detecting cancer by measuring lipid-peroxidation¹using nmr
WO1992011807A1 (fr) Procede de detection et de localisation du cancer
McGowan et al. Quantitative 1H-NMR analysis of amniotic fluid
JPH07102207B2 (ja) 核磁気共鳴装置
WO1993021517A1 (fr) MESURE DE PROPENSION A l'ATHEROSCLEROSE; CAPACITE D'OXYDATION DE RESIDUS D'OLEFINES DES LIPOPROTEINES ET DES LIPIDES DU PLASMA
Otvos et al. An improved method for the detection of malignancy by proton NMR spectroscopy of plasma
EP0494969A1 (fr) Appareil et procede de detection du cancer par resonance magnetique nucleaire
EP3948243A1 (fr) Instrumentation de résonance magnétique nucléaire portable et procédés d'analyse de fluides corporels
Petit et al. T1-dispersion curves modelling and analysis of human glioma resections: a novel biomarker of molecular dynamics
Cheng et al. Proton NMR Analysis of Human Prostate Tissue with Slow Rate High Resolution Magic Angle Spinning:(A+ B-| AB|)

Legal Events

Date Code Title Description
FZDE Dead